Greenwich LifeSciences (GLSI) Financials

Greenwich LifeSciences, Inc. (GLSI) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. In order to assess the financial performance of the company, it is necessary to examine its income statement, balance sheet, and cash flow. The income statement provides a snapshot of the revenue and expenses incurred by GLSI during a specific period of time. It includes key financial metrics such as gross profit, EBIT (Earnings Before Interest and Taxes), EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), and net income from stockholders. These metrics help to evaluate the profitability and operational efficiency of the company. GLSI's total revenue reflects the sum of all sales made during the period.

The balance sheet presents a summary of GLSI's financial position at a specific point in time. It includes information on the company's total assets, total liabilities, and stockholders equity. Total assets represent the value of GLSI's resources, including cash equivalents, investments, property, and intangible assets. Total liabilities encompass the company's debts and obligations. Stockholders equity represents the difference between total assets and total liabilities, reflecting the shareholders' ownership interest in the company. Net debt is a measure of GLSI's financial leverage, calculated as total debt minus cash equivalents. It indicates the company's ability to meet its debt obligations.

Cash flow statement provides insights into GLSI's sources and uses of cash during a specific period. It consists of three sections: operating cash flow, investing cash flow, and financing cash flow. Operating cash flow reflects the cash generated from the company's core operations, including revenue from sales and payments for expenses. Investing cash flow represents the cash used for long-term investments, such as the purchase of property or acquisition of other companies. Financing cash flow reflects the cash sources and uses related to financial activities, such as issuing or repurchasing stock, paying dividends, or obtaining or repaying debt. Free cash flow is a measure of GLSI's cash generation after accounting for capital expenditures necessary to maintain or expand its business.